IP Library Granted Patent US 10,980,913
Granted Patent B2
US 10,980,913 · App. 15/911,859 · Granted Apr 20, 2021

Sealant foam compositions for lung applications

Inventors: Sridevi N. Dhanaraj (Raritan, NJ); Nir I. Nativ (West Orange, NJ); Ashley DeAnglis (Skillman, NJ)
Assignee: Ethicon LLC
A61L24/0036A61L24/0042A61L24/02A61L24/043C08J9/0061C08J9/125A61L2400/04A61L2400/06C08J2203/10C08J2207/10C08J2389/00C08J2471/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,980,913
App. No.
15/911,859
Granted
Apr 20, 2021
Kind
B2
Abstract

The present invention is directed to tissue sealant compositions comprising: a multi-arm reactive polyethylene glycol polymer having at least 3 electrophilic groups; albumin; a buffer; water; and entrained gas as bubbles; wherein concentration of albumin in a liquid component of the sealant is within range of 50-200 mg/ml; and wherein concentration of multi-arm PEG in said liquid component of the sealant is within range of 25-100 mg/mL.

Claims (24)

1. A tissue sealant comprising:

a) a multi-arm PEG having at least 3 electrophilic groups;

b) albumin;

c) a buffer;

d) water; and

e) entrained gas as bubbles;

wherein when components (a-e) of the tissue sealant are combined produce a compliant soft set foam with closed cell;

wherein concentration of albumin in a liquid component of the sealant is within range of 50-200 mg/ml; and

wherein concentration of multi-arm PEG in said liquid component of the sealant is within range of 25-100 mg/mL,

wherein gas comprises 65% to 75% of the foam by volume, and

wherein E modulus of the foam in a cured state is above 8.5 kPa and below 110 kPa.

2. The tissue sealant of claim 1 , wherein said gas is air, nitrogen, argon, carbon dioxide, or mixtures thereof.

3. The tissue sealant of claim 1 , wherein said multi-arm PEG has molecular weight from about 5 kD to about 20 kD.

4. The tissue sealant of claim 1 , wherein said multi-arm PEG comprises diester linkages.

5. The tissue sealant of claim 1 , wherein said electrophilic groups are hydroxysuccinimide (NHS) or succinimidyl glutarate ester (SG).

6. The tissue sealant of claim 1 , wherein said sealant comprises a foam and is bioresorbable.

7. The tissue sealant of claim 6 , wherein foam flowability is such that the foam requires at least 7 seconds to travel 6 inches on a 30% inclined panel.

8. The tissue sealant of claim 6 , wherein albumin and PEG-SG concentrations in mg/mL of liquid portion of the foam, are selected so that an equation for E Modulus yields values from 8.5 kPa to 110 kPa:

E Modulus ( k Pa)=−2.34−0.168Albumin+0.197 PEG+ 0.000393Albumin{circumflex over ( )}2−0.00462 PEG{circumflex over ( )} 2+0.008318Albumin* PEG.

9. A method of making the tissue sealant of claim 1 , comprising: mixing and foaming a composition comprising multi-arm PEG-SG, albumin, buffer, water, and gas.

10. A method of using the tissue sealant of claim 1 , comprising:

rapidly mixing and foaming a composition comprising multi-arm PEG-SG, albumin, buffer, water, and gas, forming a foam;

immediately thereafter applying the foam onto a tissue;

allowing the foam to cure on said tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056983/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2018
From: NATIV, NIR I.; DEANGLIS, ASHLEY; DHANARAJ, SRIDEVI N.
To: ETHICON LLC
Reel/Frame 046130/0903 →
Cited By (2)
US 12,599,624 US 12,673,129